In a contradicting study by Qaisar et al. (2023), they investigated plasma zonulin levels in different patient groups, including those with mild AD (n = 71), moderate AD (n = 66), and a control group (n = 74) [68]. This evidence concerns the gene HP and Alzheimer disease.